CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 177,278	$ 30,294
Restricted cash	3,049	66,196
Patient accounts receivable	249,030	237,596
Prepaid expenses	10,788	8,243
Other current assets	9,395	8,225
Total current assets	449,540	350,554
Property and equipment, net of accumulated depreciation of $100,963 and $96,137	25,007	28,113
Operating lease right of use assets	92,904	84,791
Goodwill	937,088	658,500
Intangible assets, net of accumulated amortization of $12,649 and $7,044	81,813	64,748
Deferred income taxes	25,463	21,427
Other assets	33,673	54,612
Total assets	1,645,488	1,262,745
Current liabilities:
Accounts payable	33,383	31,259
Payroll and employee benefits	128,275	120,877
Accrued expenses	169,722	137,111
Provider relief fund advance	70,000	0
Current portion of long-term obligations	10,718	9,927
Current portion of operating lease liabilities	29,950	27,769
Total current liabilities	442,048	326,943
Long-term obligations, less current portion	392,713	232,256
Operating lease liabilities, less current portion	61,611	56,128
Other long-term obligations	26,857	5,905
Total liabilities	923,229	621,232
Commitments and Contingencies—Note 5
Equity:
Preferred stock, $0.001 par value, 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock, $0.001 par value, 60,000,000 shares authorized; 36,831,298 and 36,638,021 shares issued; and 32,442,719 and 32,284,051 shares outstanding	37	37
Additional paid-in capital	665,580	645,256
Treasury stock, at cost 4,388,579 and 4,353,970 shares of common stock	(257,625)	(251,241)
Accumulated other comprehensive income	0	15
Retained earnings	312,859	246,383
Total Amedisys, Inc. stockholders’ equity	720,851	640,450
Noncontrolling interests	1,408	1,063
Total equity	722,259	641,513
Total liabilities and equity	$ 1,645,488	$ 1,262,745